Gujarat Kidney and Super Speciality share news and announcements
NSE: GKSLBSE: 544666Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹179.46.
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,391 Cr1,531st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 Jul 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 8.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 Jul 2026
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 5,64,91540.6% delivered
Next board meeting and results date
As the company gave notice to the exchange.Gujarat Kidney and Super Speciality quarterly results
The board meets on 4 Nov 2026 to consider financial results
Notice filed 23 Oct 2026
Gujarat Kidney and Super Speciality annual reports, presentations and earnings calls
The company's own documents, latest first.Gujarat Kidney and Super Speciality financials, year by year
Annual reports1
Investor presentations1
Gujarat Kidney and Super Speciality share news and announcements
47 announcements, routine notices left out, newest first.
Oct 2026
Sep 2026
1 Sep · General Updates
Aug 2026
27 Aug · Analysts
14 Aug · Management
3 Aug · Legal
Exchange has sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Jul 2026
23 Jul · Meeting
Jun 2026
25 Jun · Legal
Exchange has sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is awaited.4 Jun · Meeting
May 2026
Apr 2026
Mar 2026
25 Mar · Meeting
25 Mar · Board meeting
21 Mar · General Updates
19 Mar · Board meeting
Feb 2026
10 Feb · Board meeting
Not held on this date
5 Feb · Board meeting
Jan 2026
6 Jan · Board meeting
2 Jan · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 17 Aug 2026Board or managers changedup 10.94%+11.1 pts vs Nifty 500market median 0.0% · five sessions +12.1% (+12.4 pts vs Nifty 500) · volume 12.4× usual · delivery −22.4 pts against usual · The announcement (opens in a new tab)
- 17 Aug 2026Resultsup 10.94%+11.1 pts vs Nifty 500market median −0.7% · five sessions +12.1% (+12.4 pts vs Nifty 500) · volume 12.4× usual · delivery −22.4 pts against usual · The announcement (opens in a new tab)
- 6 Aug 2026Resultsdown 0.46%−0.4 pts vs Nifty 500market median −0.7% · five sessions −1.0% (−0.8 pts vs Nifty 500) · volume 3.4× usual · delivery −28.3 pts against usual · The announcement (opens in a new tab)
- 4 Mar 2026Board or managers changeddown 1.32%+0.5 pts vs Nifty 500market median 0.0% · five sessions −1.0% (+1.1 pts vs Nifty 500) · volume 0.3× usual · delivery −7.7 pts against usual · The announcement (opens in a new tab)
Gujarat Kidney and Super Speciality results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Net change in cash | Year to date to Sep 2025 | Consolidated | 0.81 | 0.89 | +9.9% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Cash generated before tax | Year to date to Sep 2025 | Consolidated | −7.67 | −7.59 | +1.0% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Net change in cash, before currency effects | Year to date to Sep 2025 | Consolidated | 0.81 | 0.89 | +9.9% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Cash from operations | Year to date to Sep 2025 | Consolidated | −7.44 | −7.36 | +1.1% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Plant in use, after depreciation | At Sep 2025 | Consolidated | 18.55 | 18.55 | 0.0% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Assets held for longer than a year | At Sep 2025 | Consolidated | 32.03 | 32.03 | 0.0% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Other assets turning to cash within a year | At Sep 2025 | Consolidated | 14.85 | 14.85 | 0.0% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Assets turning to cash within a year | At Sep 2025 | Consolidated | 43.65 | 43.64 | 0.0% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Cash at the end of the period | At Sep 2025 | Consolidated | 3.41 | 3.49 | +2.3% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |
| Change in other current financial liabilities | Year to date to Sep 2025 | Consolidated | −0.19 | −0.11 | +42.4% | 18 Apr 2026 (opens in a new tab) | 5 Aug 2026 (opens in a new tab) |